KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Change in Intangibles (2020 - 2024)

Aurinia Pharmaceuticals' Change in Intangibles history spans 4 years, with the latest figure at $129000.0 for Q3 2024.

  • For Q3 2024, Change in Intangibles rose 360.71% year-over-year to $129000.0; the TTM value through Sep 2024 reached $253000.0, up 5.42%, while the annual FY2019 figure was $16000.0, N/A changed from the prior year.
  • Change in Intangibles reached $129000.0 in Q3 2024 per AUPH's latest filing, up from $84000.0 in the prior quarter.
  • In the past five years, Change in Intangibles ranged from a high of $162000.0 in Q1 2023 to a low of -$83000.0 in Q4 2021.
  • Average Change in Intangibles over 4 years is $46636.4, with a median of $48000.0 recorded in 2020.
  • The largest YoY upside for Change in Intangibles was 360.71% in 2024 against a maximum downside of 92.59% in 2024.
  • A 4-year view of Change in Intangibles shows it stood at $4000.0 in 2020, then crashed by 2175.0% to -$83000.0 in 2021, then surged by 133.73% to $28000.0 in 2023, then skyrocketed by 360.71% to $129000.0 in 2024.
  • Per Business Quant, the three most recent readings for AUPH's Change in Intangibles are $129000.0 (Q3 2024), $84000.0 (Q2 2024), and $12000.0 (Q1 2024).